Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan

Clostridium butyricum Bacteremia Associated with Probiotic Use, Japan

Clostridium butyricum, a probiotic commonly prescribed in Asia, most notably as MIYA-BM (Miyarisan Pharmaceutical Co., Ltd.; https://www.miyarisan.com), occasionally leads to bacteremia. The prevalence and characteristics of C. butyricum bacteremia and its bacteriologic and genetic underpinnings re...

Full description

Bibliographic Details
Main Authors: Ryuichi Minoda Sada, Hiroo Matsuo, Daisuke Motooka, Satoshi Kutsuna, Shigeto Hamaguchi, Go Yamamoto, Akiko Ueda
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2024-04-01
Series:Emerging Infectious Diseases
Subjects:
Clostridium butyricum
bacteremia
probiotics
Japan
inappropriate prescribing
bacteria
Online Access:https://wwwnc.cdc.gov/eid/article/30/4/23-1633_article

Internet

https://wwwnc.cdc.gov/eid/article/30/4/23-1633_article

Similar Items